An antibody cocktail is now beginning late-stage clinical trials to evaluate the drug’s ability to prevent and treat coronavirus infection.
An antibody cocktail is now beginning late-stage clinical trials to evaluate the drug’s ability to prevent and treat coronavirus infection.
